NEWS RELEASE
MYM Appoints New Chief Financial Officer
Vancouver, B.C., February 28, 2018 – MYM Nutraceuticals Inc., (CSE: MYM) (the “Company” or “MYM”) is pleased to announce Craig Lennox has joined MYM as its new Chief Financial Officer (CFO) effective February 26, 2018. Lennox joins MYM from Clearly, a leading online optical retailer, where he was most recently Chief Financial Officer. Lennox is Chartered Professional Accountant (CA) and brings with him an extensive background in public accounting and broad experience in financial management.
“It is an exciting time to be entering into the cannabis space and I’m pleased to be joining the MYM team to help execute in bringing the various MYM projects to market,” commented Lennox.
Lennox will lead MYM’s financial operations, and will report directly to Rob Gietl, MYM’s CEO. Craig succeeds Mark Forster who will stay on with MYM in a supporting role.
Mr. Lennox was granted 800,000 options to purchase MYM common shares, pursuant to the Company’s Stock Option Plan. The options are exercisable for a period of two years, after they vest, at a price of $1.98 per share. 200,000 of the options will vest on February 26, 2019, and 50,000 every quarter thereafter.
About MYM Nutraceuticals Inc.
MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end organic medicinal cannabis supplements and topical products. MYM has two production projects in Quebec that when completed will have over 1.5 million sf of production space. MYM is also a partner in a 1.2 million sf production project (Northern Rivers Project) in New South Wales, Australia. Australia is an exciting new market that has recently legalized medicinal cannabis. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE: MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).
ON BEHALF OF THE BOARD
Rob Gietl, CEO
MYM Nutraceuticals Inc.
www.mymarijuana.ca
Investor Relations
Terry Brown
1.855.696.2261
terry@mymarijuana.ca
Keep up to date with MYM on our social media channels:
Twitter: @MYM_Nutra
Facebook: @mymcanada
Instagram: @MYM_Nutra
This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results, including with respect to the MOU and the transaction contemplated thereby (the “Transaction”) and the Company’s plans, objectives and expected outcomes. In making the forward-looking statements, the Company has applied several material assumptions including, but not limited to, the assumptions that: definitive Transaction agreements will be entered into and the Transaction will proceed and be completed as planned, the expected benefits from the Transaction will be achieved and required regulatory approvals will be obtained. These forward-looking statements address future events and conditions and, as such, involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the statements. Such factors include, among others and in addition to those described elsewhere in this release, inability to obtain regulatory approvals of the Transaction, inability to complete the Transaction on the proposed terms or at all, that the Transaction, if completed, will not result in the expected benefits to the Company, inability to achieve desired outcomes and delays in obtaining or inability to obtain required government or other regulatory approvals. The Company disclaims any intention or obligation to revise or update such statements, except as required by applicable securities legislation. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.
This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the “United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.
|
Thread abonnieren
